YC Biotech Founder Wants to End All Rare Disease - Ethan Perlstein (Ep. 11)

from bio/acc Podcast · host Shriya Bhat, Harvard BCI

In this episode, I talk to Ethan Perlstein, a YC biotech founder who wants to make better drugs and financial incentives for curing rare diseases. We discuss the post-academic collapse in science careers, the financial abandonment of most rare diseases, and how crypto and AI could revolutionize drug development.

Episode metadata supplied by the publisher feed · Published Jul 22, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

YC Biotech Founder Wants to End All Rare Disease - Ethan Perlstein (Ep. 11)

0:00 38:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of bio/acc Podcast?

This episode is 38 minutes long.

When was this bio/acc Podcast episode published?

This episode was published on July 22, 2025.

Can I download this bio/acc Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!